Yuko Aoki

3.7k total citations · 1 hit paper
71 papers, 3.0k citations indexed

About

Yuko Aoki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Yuko Aoki has authored 71 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Organic Chemistry. Recurrent topics in Yuko Aoki's work include Antifungal resistance and susceptibility (8 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and biological activity (5 papers). Yuko Aoki is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and biological activity (5 papers). Yuko Aoki collaborates with scholars based in Japan, United States and Switzerland. Yuko Aoki's co-authors include Nobuya Ishii, Nobuo Shimma, Takuo Tsukuda, Hiroshi Sakamoto, Mikio Arisawa, Toshiyuki Tsukaguchi, Takaaki A. Fukami, Hirosato Ebiike, Kiyoaki Sakata and Tatsushi Kodama and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Yuko Aoki

70 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant

2011 508 citations Hiroshi Sakamoto, Toshiyuki Tsukaguchi et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuko Aoki Japan	27	1.4k	700	698	568	314	71	3.0k
Pavel Majer Czechia	31	1.6k 1.1×	640 0.9×	565 0.8×	405 0.7×	182 0.6×	117	3.3k
George L. Trainor United States	37	2.3k 1.6×	541 0.8×	1.6k 2.4×	149 0.3×	179 0.6×	83	4.5k
Wenlong Huang China	33	1.8k 1.2×	637 0.9×	755 1.1×	417 0.7×	166 0.5×	222	4.1k
William Furey United States	38	2.0k 1.4×	1.6k 2.3×	330 0.5×	229 0.4×	318 1.0×	86	6.2k
Leonard Liebes United States	39	2.5k 1.7×	2.1k 3.1×	256 0.4×	780 1.4×	426 1.4×	129	6.2k
Sally Freeman United Kingdom	29	1.7k 1.2×	421 0.6×	758 1.1×	72 0.1×	151 0.5×	156	3.2k
David S. Duch United States	25	1.2k 0.8×	263 0.4×	548 0.8×	120 0.2×	139 0.4×	62	2.6k
Dante Rotili Italy	46	3.7k 2.6×	931 1.3×	878 1.3×	147 0.3×	1.2k 3.7×	179	6.4k
Daniel A. Bachovchin United States	34	4.1k 2.9×	1.0k 1.5×	1.1k 1.6×	139 0.2×	283 0.9×	54	5.5k
Angela Nebbioso Italy	41	4.0k 2.8×	840 1.2×	678 1.0×	225 0.4×	565 1.8×	127	6.0k

Countries citing papers authored by Yuko Aoki

Since Specialization

Citations

This map shows the geographic impact of Yuko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Aoki more than expected).

Fields of papers citing papers by Yuko Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Aoki. The network helps show where Yuko Aoki may publish in the future.

Co-authorship network of co-authors of Yuko Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Aoki. A scholar is included among the top collaborators of Yuko Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Aoki. Yuko Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakatani, Yoshihiko, et al.. (2023). Inhibitory effect of atomoxetine on Nav1.2 voltage-gated sodium channel currents. Pharmacological Reports. 75(3). 746–752. 1 indexed citations

Nakamura, Daisuke, Kazuyoshi Iida, Kayo Horibuchi, et al.. (2022). Mechanism and enhancement of anti-parasitic-reaction catalytic activity of tungsten-carbide-coated graphite components for the growth of bulk GaN crystals. Applied Physics Express. 15(4). 45501–45501.

Nakanishi, Yoshito, Hideaki Mizuno, Hitoshi Sase, et al.. (2015). ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor. Molecular Cancer Therapeutics. 14(12). 2831–2839. 24 indexed citations

Nakanishi, Yoshito, Toshiyuki Tsukaguchi, Toshihiko Fujii, et al.. (2014). The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor. Molecular Cancer Therapeutics. 13(11). 2547–2558. 101 indexed citations

Ishii, Nobuya, Naoki Harada, Eric W. Joseph, et al.. (2013). Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity. Cancer Research. 73(13). 4050–4060. 128 indexed citations

Katsume, Asao, Yuko Tokunaga, Yuichi Hirata, et al.. (2013). A Serine Palmitoyltransferase Inhibitor Blocks Hepatitis C Virus Replication in Human Hepatocytes. Gastroenterology. 145(4). 865–873. 32 indexed citations

Konishi, Hideyuki, Koichi Okamoto, Hitoshi Yoshino, et al.. (2012). An orally available, small-molecule interferon inhibits viral replication. Scientific Reports. 2(1). 259–259. 39 indexed citations

Kashima, Kenji, Miho Watanabe, Yasuko Satoh, et al.. (2012). Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor‐D. Cancer Science. 103(12). 2144–2152. 18 indexed citations

Tanaka, Hiroshi, Miyuki Yoshida, Hiromi Tanimura, et al.. (2011). The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations. Clinical Cancer Research. 17(10). 3272–3281. 79 indexed citations

10.

Ono, Naomi, Toshikazu Yamazaki, Yoshito Nakanishi, et al.. (2011). Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)‐overexpressing cancers. Cancer Science. 103(2). 342–349. 21 indexed citations

11.

Sakamoto, Hiroshi, Toshiyuki Tsukaguchi, Tatsushi Kodama, et al.. (2011). CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant. Cancer Cell. 19(5). 679–690. 508 indexed citations breakdown →

12.

Miura, Takaaki, Takaaki A. Fukami, Kiyoshi Hasegawa, et al.. (2011). Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design. Bioorganic & Medicinal Chemistry Letters. 21(19). 5778–5783. 28 indexed citations

13.

Asoh, Kohsuke, Tatsuo Ohtsuka, Miyako Masubuchi, et al.. (2009). Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1753–1757. 39 indexed citations

14.

Sogabe, Satoshi, Miyako Masubuchi, Kiyoaki Sakata, et al.. (2002). Crystal Structures of Candida albicans N-Myristoyltransferase with Two Distinct Inhibitors. Chemistry & Biology. 9(10). 1119–1128. 107 indexed citations

15.

Kondoh, Osamu, Tsuyoshi Takasuka, Mikio Arisawa, Yuko Aoki, & Takahide Watanabe. (2002). Differential Sensitivity between Fks1p and Fks2p against a Novel β-1,3-Glucan Synthase Inhibitor, Aerothricin1. Journal of Biological Chemistry. 277(44). 41744–41749. 11 indexed citations

16.

Ebiike, Hirosato, Miyako Masubuchi, Pingli Liu, et al.. (2002). Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2. Bioorganic & Medicinal Chemistry Letters. 12(4). 607–610. 66 indexed citations

17.

Thomson, Lynn, Steven Bates, Soh Yamazaki, et al.. (2000). Functional Characterization of the Candida albicans MNT1Mannosyltransferase Expressed Heterologously in Pichia pastoris. Journal of Biological Chemistry. 275(25). 18933–18938. 22 indexed citations

18.

Sugiura, Tomoko, Eriko Tanaka, Shinji Sakamoto, et al.. (1999). Reliability of childhood mental disorder: Diagnoses by Japanese psychologists. Psychiatry and Clinical Neurosciences. 53(1). 57–61. 3 indexed citations

19.

Inoue, Kyoko, Yuko Aoki, Mikio Hayashi, et al.. (1995). Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits.. PubMed. 45(9). 980–4. 3 indexed citations

20.

Kamata, Katsuo, et al.. (1991). Pharmacological actions of chemically-modified phospholipase A2 from the venom of Trimeresurus flavoviridis on the smooth muscle of the rat stomach fundus.. PubMed. 74(3). 375–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact